Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06574113 · ClinicalTrials.gov registry record

Validation of Cuffless Blood Pressure Measurements Using the Perin Health Patch

A clinical trial of Blood Pressure, sponsored by Perin Health Devices.

Recruiting
Registry status
85
Enrollment target
1
Study location

NCT06574113: Recruiting study of Blood Pressure, sponsored by Perin Health Devices.

NCT06574113 is a study of Blood Pressure that is actively recruiting participants, run by Perin Health Devices. The registered enrollment target is 85 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06574113, a study of Blood Pressure, is actively recruiting participants, sponsored by Perin Health Devices.

RECRUITING
Registry status
85 participants
Enrollment target
1
Study location

Study Summary

This study aims to validate a proprietary cuffless blood pressure algorithm using measurements from a multi-modal chest-worn medical device, the Perin Health Patch (PHP).

Conditions Studied

Interventions

  • DEVICE Perin Health Patch

Study Locations (1)

California

  • Perin Health Devices - Woodland Hills

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2024-08-15
Est. Completion 2024-12-31
Perin Health Devices

5 total trials

What NCT06574113 shows while recruiting

NCT06574113 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Perin Health Patch is the first listed.

NCT06574113 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06574113 about?

NCT06574113 is a clinical study titled "Validation of Cuffless Blood Pressure Measurements Using the Perin Health Patch". This study aims to validate a proprietary cuffless blood pressure algorithm using measurements from a multi-modal chest-worn medical device, the Perin Health Patch (PHP).

What is the current status of trial NCT06574113?

This trial is currently recruiting. The enrollment target is 85 participants. The study started on 2024-08-15. Estimated completion is 2024-12-31.

What conditions does trial NCT06574113 study?

This clinical trial studies the following conditions: Blood Pressure.

What interventions are being tested in trial NCT06574113?

The interventions under investigation include: Perin Health Patch (DEVICE).

Who is sponsoring clinical trial NCT06574113?

This trial is sponsored by Perin Health Devices, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06574113 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06574113's enrollment target sits among peer trials

85 43rd of 101 higher than 59 of 101 other Blood Pressure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00842283 · 85 participants

    Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target

  • NCT02133196 · 85 participants · Phase 2

    T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

  • NCT03823144 · 85 participants · NA

    Intravital Microscopy in Human Solid Tumors

  • NCT03875638 · 85 participants · Phase 2

    Treating Hyperexcitability in AD With Levetiracetam

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06574113, the US trial registry maintained by the National Library of Medicine. NCT06574113 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.